NCT05967026

Brief Summary

The goal of this monocentric observationnal study is to describe the characteristics of the myocardial infarction scar in terms of transmurality in residual LVEF\>35% patients. The primary objective is to determine the frequency of the criterion "intramural scar ≥1.47cm2" (measured by MRI) in patients who presented with myocardial infarction with residual LVEF≥35%.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

July 13, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

August 1, 2023

Status Verified

July 1, 2023

Enrollment Period

Same day

First QC Date

July 13, 2023

Last Update Submit

July 28, 2023

Conditions

Myocardial Infarction

Keywords

cardiac magnetic resonancesudden cardiac deathrisk stratification

Outcome Measures

Primary Outcomes (1)

  • Intramural scar surface in cm²

    Intramural scar surface in cm²\>1.47cm²

    6 weeks after myocardial infarction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient with a history of acute coronary syndrome prior to inclusion and having undergone cardiac MRI and LVEF \>35% measured at least 6 weeks post-IDM by echocardiography or MRI

You may qualify if:

  • Age ≥ 18 years ;
  • LVEF \>35% measured at least 6 weeks post-IDM by echocardiography or MRI;

You may not qualify if:

  • \- Patient with an implantable cardiac device (implantable cardioverter defibrillator or pacemaker) prior to MRI.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU of Nancy

Nancy, 54000, France

Location

MeSH Terms

Conditions

Myocardial InfarctionDeath, Sudden, Cardiac

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisHeart ArrestDeath, SuddenDeath

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Residant in Cardiology Unit

Study Record Dates

First Submitted

July 13, 2023

First Posted

August 1, 2023

Study Start

July 1, 2023

Primary Completion

July 1, 2023

Study Completion

August 1, 2023

Last Updated

August 1, 2023

Record last verified: 2023-07

Locations

FR(1)